Core Points - The announcement indicates that the actual controllers of Keqian Bio, He Qigai, Wu Bin, Fang Liurong, and Wu Meizhou, have renewed the "Consistent Action Agreement" on September 17, 2025, which was originally set to be renewed on September 20, 2024 [1] - The new agreement clarifies the purpose of consistent action and decision-making mechanisms, extending its validity until September 21, 2026 [1] - As of the announcement date, the four individuals collectively hold 27.48% of the company's shares, ensuring stability in the company's control and maintaining strategic and operational continuity [1] - The renewal of the agreement is expected to promote healthy and sustainable development without harming the interests of minority investors [1]